| SPECIES CROSSREACTIVITY: |
|
| MW: |
~35kDa (SDS-PAGE). |
| SOURCE/HOST: |
Produced in HEK 293 cells. The extracellular domain of mouse BAFF-R (aa 2-70) is fused at the C-terminus to a linker peptide (10 aa) and the Fc portion of human IgG1. |
| CONCENTRATION: |
1mg/ml (after reconstitution). |
| PURITY: |
≥95% (SDS-PAGE) |
| FORMULATION: |
Lyophilized. Contains PBS. |
| ENDOTOXIN CONTENT: |
<0.1EU/µg purified protein (LAL test; BioWhittaker). |
| RECONSTITUTION: |
Reconstitute with 50µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or a carrier protein. |
| SPECIFICITY: |
Binds mouse and human BAFF. |
| BIOLOGICAL ACTIVITY: |
Blocks the binding of mouse and human BAFF to their BAFF-receptors, inhibiting BAFF-mediated splenocyte survival. |
| APPLICATION: |
Flow Cytometry: Detection of membrane-bound mouse and human BAFF. |
| SHIPPING: |
SHIPPED ON BLUE ICE |
| LONG TERM STORAGE: |
-20°C |
| USE/STABILITY: |
Stable for at least 6 months after receipt when stored at -20°C. |
| HANDLING: |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. |
